Epicrestal and subcrestal placement of platform-switched implants: 18 month-result of a randomized, controlled, split-mouth, prospective clinical trial

Clinical Oral Implants Research
Stuart FroumIsmael Khouly

Abstract

To evaluate the changes in marginal bone levels (MBL) and soft tissue dimension around platform-switched implants with the implant-abutment junction (IAJ) placed at the crest or 1.5-2 mm subcrestally. In all, 96 platform-switched implants were placed in either the posterior maxilla or mandible in 48 partially edentulous patients in a split-mouth study. All implants were provisionally restored after 4-5 months and definitively after 6 months (T6). Radiographic assessment of MBL was assessed at implant placement (T0), T6, 12 months (T12), and 18 months (T18) after placement. Mid-buccal soft tissue and papilla measurements were performed at T6, T12, and T18. In all, 43 patients with 86 implants completed the study. The T18 examination showed an implant survival rate of 100% in both groups. Analysis showed that MBL varied as a function of IAJ location, which indicated more coronal bone levels with subcrestal (2.39 ± 0.08 mm) than with epicrestal placements (0.88 ± 0.08 mm) (p < .05). Greater average marginal bone loss was found in the subcrestal group (0.40 ± 0.07 mm) compared to the epicrestal group (0.13 ± 0.08 mm) although no statistically significant difference was found at T18 (p > .05). Levels of mid-buccal soft tissue had no...Continue Reading

References

Jun 1, 1986·Journal of Bioluminescence and Chemiluminescence·R P RaunioA M Kuusinen
Aug 1, 1997·Journal of Clinical Psychopharmacology·E M Szigethy, S C Schulz
Aug 1, 1997·Journal of Clinical Periodontology·I AbrahamssonJ Lindhe
Dec 12, 2001·Clinical Oral Implants Research·J S HermannD L Cochran
Oct 11, 2003·Clinical Implant Dentistry and Related Research·Ingemar AbrahamssonJan Lindhe
Jul 17, 2004·The Journal of Oral Implantology·Georg H Nentwig
Jul 17, 2004·The Journal of Oral Implantology·Paul Weigl
Jul 17, 2004·The Journal of Oral Implantology·G E Romanos
Nov 9, 2005·Journal of Periodontology·George E RomanosAdriano Piattelli
Apr 25, 2006·Journal of Dental Research·N BrogginiD L Cochran
Sep 14, 2006·Clinical Oral Implants Research·Flemming Isidor
Nov 5, 2008·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Markus HürzelerHannes C Wachtel
Dec 25, 2007·The Korean journal of laboratory medicine·Se Ran HeoEui Chong Kim
Apr 22, 2008·Journal of Clinical Periodontology·Juan BlancoIsabel Ramos
Apr 29, 2009·Clinical Oral Implants Research·Maria WelanderTord Berglundh
Jun 19, 2009·Statistics in Medicine·Emmanuel LesaffreHelen Worthington
Jan 15, 2010·Clinical Oral Implants Research·Luigi CanulloSøren Jepsen
May 29, 2010·Journal of Clinical Periodontology·Christer FranssonTord Berglundh
Oct 27, 2010·Biomedizinische Technik. Biomedical Engineering·Friedhelm HeinemannTorsten Mundt
Feb 16, 2011·Clinical Oral Implants Research·Norbert EnklingSøren Jepsen
Mar 26, 2011·Clinical Oral Implants Research·José Luis Calvo-GuiradoJosé María Martínez-González
Mar 16, 2013·Clinical Implant Dentistry and Related Research·Erhan DursunTolga F Tözüm
May 17, 2013·Clinical Implant Dentistry and Related Research·Georgios E RomanosGeorg-Hubertus Nentwig

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.